BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 26205403)

  • 1. The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis.
    Moles R; Nicot C
    Viruses; 2015 Jul; 7(7):4047-74. PubMed ID: 26205403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNAs in HTLV-1 infection and transformation.
    Ruggero K; Corradin A; Zanovello P; Amadori A; Bronte V; Ciminale V; D'Agostino DM
    Mol Aspects Med; 2010 Oct; 31(5):367-82. PubMed ID: 20600265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
    D'Agostino DM; Zanovello P; Watanabe T; Ciminale V
    Adv Cancer Res; 2012; 113():45-83. PubMed ID: 22429852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.
    Bai XT; Nicot C
    J Biol Chem; 2015 Feb; 290(9):5381-90. PubMed ID: 25568327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
    Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
    Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1 and associated adult T-cell leukemia/lymphoma.
    Mahieux R; Gessain A
    Rev Clin Exp Hematol; 2003 Dec; 7(4):336-61. PubMed ID: 15129647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeting for treatment of human T-lymphotropic virus type 1 infection.
    Soltani A; Hashemy SI; Zahedi Avval F; Soleimani A; Rafatpanah H; Rezaee SA; Griffith R; Mashkani B
    Biomed Pharmacother; 2019 Jan; 109():770-778. PubMed ID: 30551530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
    Bangham CR; Toulza F
    Adv Cancer Res; 2011; 111():163-82. PubMed ID: 21704832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.
    Chan CP; Kok KH; Jin DY
    Adv Exp Med Biol; 2017; 1018():147-166. PubMed ID: 29052136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission.
    Percher F; Jeannin P; Martin-Latil S; Gessain A; Afonso PV; Vidy-Roche A; Ceccaldi PE
    Viruses; 2016 Feb; 8(2):. PubMed ID: 26848683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
    Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
    Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of human T-lymphotropic virus type 1 transmission and disease.
    Lairmore MD; Haines R; Anupam R
    Curr Opin Virol; 2012 Aug; 2(4):474-81. PubMed ID: 22819021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells.
    Tomita M; Tanaka Y; Mori N
    Int J Cancer; 2012 May; 130(10):2300-9. PubMed ID: 20017139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Studies of HTLV-1 Replication: An Update.
    Martin JL; Maldonado JO; Mueller JD; Zhang W; Mansky LM
    Viruses; 2016 Jan; 8(2):. PubMed ID: 26828513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH).
    Ohshima K; Suzumiya J; Izumo S; Mukai Y; Tashiro K; Kikuchi M
    Int J Cancer; 1996 Mar; 66(1):18-23. PubMed ID: 8608960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo.
    Etoh K; Tamiya S; Yamaguchi K; Okayama A; Tsubouchi H; Ideta T; Mueller N; Takatsuki K; Matsuoka M
    Cancer Res; 1997 Nov; 57(21):4862-7. PubMed ID: 9354450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30 years after virus discovery.
    Jeang KT
    J Formos Med Assoc; 2010 Oct; 109(10):688-93. PubMed ID: 20970064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo.
    Mortreux F; Gabet AS; Wattel E
    Leukemia; 2003 Jan; 17(1):26-38. PubMed ID: 12529656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma.
    Yoshimitsu M; White Y; Arima N
    Recent Results Cancer Res; 2014; 193():211-25. PubMed ID: 24008301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.